13.12.12
£18m cancer research centre opens
A new cancer research centre has been officially opened in Surrey.
The £18m Centre for Molecular Pathology in Sutton has been opened by The Royal Marsden and the Institute of Cancer Research (ICR).
Designed and built by Osborne, the centre will advance cancer research and provide testing and treatment for cancer patients. The building consists of four lab suites and support facilities, with state of the art equipment.
Sustainability was also a main focus for the centre, with a building management system and photovoltaic panels installed.
Professor David Cunningham, director of research and development at The Royal Marsden, said: “At The Royal Marsden and the ICR we are leading the way in providing patients with routine molecular diagnosis which helps identify which patients will benefit from which therapies.
“The Centre for Molecular Pathology is an exciting new facility which will drive a move towards personalised medicine and will enable us to continue working to revolutionise the diagnosis and treatment of cancer. This is an incredibly exciting time for cancer research, with the prospect of significant improvements in patient care.”
Elizabeth Smith, business unit leader of Osborne’s healthcare team, said: “The Centre will bring together clinicians, geneticists, pathologists and scientists from The Royal Marsden and The Institute of Cancer Research. Currently split across separate sites, the Centre will bring them under one roof for the first time.
“This will dramatically speed up the research and treatment development process. Working side by side they will be able to better understand each patient's individual tumour type and to develop personalised treatment plans faster than ever before, making The Royal Marsden's vision of personalised medicine a reality.”
Tell us what you think – have your say below, or email us directly at [email protected]